RNU6-470P

Across TCGA pan-cancer cohorts, RNU6-470P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-470P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RNU6-470P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-470P expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.

DLBC, ESCA, and LAML are the cancer types where RNU6-470P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	36	view →
ESCA	DFS	Tertile	III,IV	0.691	0.362	.020	36	view →
LAML	DFS	Tertile	All	1.000	0.334	.012	30	view →
STAD	OS	Tertile	II,III,IV	0.479	0.735	.019	18	view →
COAD	OS	Tertile	III,IV	0.208	0.791	.008	9	view →
THCA	OS	Tertile	III,IV	0.367	0.901	.030	9	view →
LGG	DFS	Tertile	All	0.461	0.827	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-470P–DLBC (OS)

Open the DLBC breakdown →